Loading...

425 posters, 1 videos, 9 audios, 8 topics, 53 sessions, 340 authors, 286 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

22nd Annual Pain Medicine Meeting 2023

November 10 - 11, 2023 | New Orleans Marriott | New Orleans, Louisiana, USA

22nd Annual Pain Medicine Meeting 2023 banner

4684

RESTORATIVE NEUROSTIMULATION FOR LOW BACK PAIN – A DISEASE MODIFYING PAIN MEDICINE THERAPY

Poster Presenter

Meredith Langhorst

Authors

Meredith Langhorst

Affiliations

OrthoIndy

Part of Topic

Chronic Pain

Restorative Neurostimulation for Chronic Low Back Pain – A disease modifying pain medicine therapy

Meredith Langhorst, MD --OrthoIndy, Fishers, IN, USA

Introduction

•Chronic low back pain (CLBP) encompasses experiences from a considerable portion of the population
•Many patients with CLBP find inadequate symptom relief from prevailing conservative management strategies
•Restorative neurostimulation is a disease-modifying intervention aimed at treating CLBP symptoms arising from impaired multifidus function
•Aim: Evaluate and present aggregate analysis from a significant volume of clinical published data across multiple clinical studies
 
Methods:
•Data was analyzed from consented patients who underwent restorative neurostimulation implantation (ReActiv8, Mainstay Medical, Ireland) in 3 major studies:
•ReActiv8-B study (US, UK, Europe, Australia
•ReActiv8-C study (Germany)
•ReActiv8-PMCF (UK)
•A cohort of 261 patients with complete records were identified out of 333 total in all studies
•Patient-reported outcomes were analyzed pre-operatively, and at 6-, 12-, and 24-months post-op:
•Numeric rating scale (NRS) or Visual Analog Scale (VAS) – recorded as response
•Oswestry Disability Index (ODI)
•EuroQol 5-Dimension 5-Level (EQ-5D-5L)
 
Combined Demographics:
•N=261;
•Females=51%;
•Agemean=49.1±0.7yrs;
•BMImean=28.4±0.3kg/m2
 
Results:

At two years of follow-up:

•ODI improved from 41 to 21
• 60% had <15-point reduction in ODI
•EQ-5D improved from 0.544 to 0.769
•65% reported < 50% reduction in pain
•60% were classified as remitters(*≤2.5 on VAS or ≤3 on NRS
 
Conclusion:

Evidence across multiple clinical studies shows consistent efficacy and durability in mechanical CLBP patients with multifidus dysfunction.

Current evidence demonstrates continued durability and efficacy with restorative neurostimulation

Patients with mechanical chronic low back pain continue to benefit in pain reduction, improved function, and quality of life over time with the implant

 

 

22nd Annual Pain Medicine Meeting 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.